You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

 

Online download statistics by month:

Online download statistics by month: April 2019 to October 2024

AbstractFullPdf
Apr 201913813149
May 2019616037
Jun 2019767238
Jul 2019333315
Aug 2019333211
Sep 2019474719
Oct 2019403716
Nov 2019282610
Dec 2019312712
Jan 2020434018
Feb 2020514412
Mar 20204941321
Apr 2020373128
May 2020312941
Jun 2020292719
Jul 2020343325
Aug 2020292711
Sep 2020726320
Oct 2020373414
Nov 2020494217
Dec 2020414015
Jan 2021201912
Feb 2021302711
Mar 2021423724
Apr 202121217
May 202140367
Jun 202124229
Jul 2021504631
Aug 2021323018
Sep 202119158
Oct 2021333331
Nov 2021261915
Dec 2021323312
Jan 2022252610
Feb 2022333322
Mar 2022373316
Apr 2022232711
May 2022333124
Jun 2022353410
Jul 2022313013
Aug 2022353512
Sep 2022383426
Oct 202227279
Nov 2022393316
Dec 202232267
Jan 2023262720
Feb 2023514513
Mar 2023414018
Apr 2023393917
May 2023141218
Jun 202322206
Jul 2023232012
Aug 202316136
Sep 202317159
Oct 202337309
Nov 2023484614
Dec 2023665610
Jan 202413148
Feb 2024403519
Mar 2024353426
Apr 2024282717
May 2024292912
Jun 202430259
Jul 2024323110
Aug 202412129
Sep 2024252213
Oct 2024242319
Total241422381403